Puma Biotechnology, Inc.PBYINASDAQ
Loading
Enterprise value to EBITDA ratio
3Y CAGR
-18.8%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.56 | +74.4% |
| 2024 | 3.19 | -34.4% |
| 2023 | 4.86 | -53.1% |
| 2022 | 10.37 | +127.5% |
| 2021 | -37.75 | -205.2% |
| 2020 | -12.37 | -62.4% |
| 2019 | -7.62 | +11.1% |
| 2018 | -8.57 | +32.1% |
| 2017 | -12.62 | -320.1% |
| 2016 | -3.00 | - |